// App-Quantinova.ai

: No Demonstrable Benefit of Penicillin in a Vaccinated Population of Children with Sickle Cell Disorder

Researchers

Presenter

  • Louise Smith

Principal Investigators

  • Elizabeth Ryan

  • Russell D Keenan

  • Rekha Thangavelu

Medical Centers

  • Haematology Treatment Centre, Alder Hey Children's Hospital, Liverpool, United Kingdom

  • Alder HEy, Liverpool, United Kingdom

  • Microbiology, Alder Hey Childrens Hospital, Liverpool, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

  • Gastroenterology (GU)

Disease

  • Sickle cell anemia

  • Hematology-oncology disease

  • Solid malignancies

  • Gastric antral vascular ectasia

Biomarkers

  • N/A

Drug/Treatment

  • Pneumococcal Conjugate Vaccine

  • Penicillin V

  • Pneumococcal Vaccine Polyvalent

  • Penicillin

  • Benzylpenicillin

  • 13-valent pneumococcal conjugate vaccine

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved